CAR-T Cell Therapy A Patent Landscape Overview | 2020 – 2025 CAR-T cell therapy represents one of the most profound shifts in cancer treatment in modern medicine, transforming a patient’s own immune cells into precision-engineered weapons capable of seeking out and destroying cancer with a level of specificity that conventional therapies cannot match. The concept […]
The Wrist That Knows You’re Sick Before You Do Consumer wearables are increasingly capable of identifying subtle physiological changes that may precede the onset of symptoms by hours, and in some cases days. 580Mglobal wearable users 1 in 14people worldwide monitored 24-48hbefore symptoms appear Consumer wearables are increasingly capable of identifying subtle physiological changes that […]
Zongertinib (Hernexeos®) HER2-Mutant NSCLC · Boehringer Ingelheim · FDA Approved 2025 & 2026 Zongertinib Hernexeos (Registered Trademark) HER2-Selective Tyrosine Kinase Inhibitor Patent & IP Patent: WO2021/213800 Priority Date: 24 April 2020 Inventor: Birgit Wilding Assignee: Boehringer Ingelheim Origin: Vienna, Austria FDA Approvals 1st Approval — August 8, 2025Previously treated HER2 TKD-mutant non-squamous NSCLC 2nd Approval […]
Legal Advantage LLC | Patents & Innovation Series Ink, Ideas & Inventions: The Weird and Wonderful World of Patent Law Patents can be legal shields, commercial weapons, speculative records, and occasionally a source of pure amusement. This article explores famous, futuristic, and wonderfully odd inventions that show the full range of human creativity. Patent LawInnovation […]
Legal Advantage LLC | Patent Landscape Report Antibody-Drug Conjugates (ADC): A Patent Landscape Overview A structured overview of global ADC patent activity, core technology domains, key jurisdictions, leading assignees, CPC classifications, and influential patent publications from 2020 to 2025. 2020 – 2025ADC Patent LandscapePharma & Biotechnologylegaladvantage.net Executive Summary 79%Increase in ADC patent applications from 2020 […]
From Invention to Litigation: How Patent Disputes Are Shaping Modern Innovation Patent litigation has never been confined to the simple enforcement of legal rights. It functions as a strategic tool through which companies protect market share, assert competitive advantage, and influence the direction of technological progress. In today's rapidly evolving business environment, patent disputes operate […]
Patent Cliffs 2025 – 2030: The $300 Billion Reckoning Every pharmaceutical executive knows the phrase. Every investor fears it. Every generic manufacturer counts down to it. The patent cliff represents the precipitous drop in revenue that follows a drug’s loss of exclusivity (LOE) which is one of the most powerful, predictable, and paradoxically disruptive forces […]
Prodrug Patents and Market Exclusivity: How Chemistry Resets the Patent Clock From inactive precursor to IP stronghold – how pharmaceutical companies extend exclusivity through prodrug innovation, and where the law draws the line. In pharmaceutical lifecycle management, few strategies are as technically elegant and as aggressively contested as the prodrug patent. A prodrug is not […]
AI in Pharma: Redefining Innovation in Healthcare Introduction “What if a computer could design the next life‑saving drug in weeks instead of decades?” This isn’t science fiction — it’s the reality Artificial Intelligence (AI) is bringing to the pharmaceutical industry. Once considered a futuristic concept, AI is now transforming drug discovery, clinical trials, diagnostics, and […]
Beating the Final Boss A Modern IP Playbook for Video Games In today’s games industry, intellectual property is the studio’s most consequential asset shaping revenue, partnerships, and long-term valuation as much as creative vision. Because every shipped title bundles multiple, distinct rights copyright in code and audiovisuals, trademarks in names and icons, design protection in […]